Navigation Links
Impac Software Introduces PowerPath(R) Version 9.3 AT USCAP
Date:3/5/2009

Impac to Demonstrate PowerPath(R) Version 9.3 at United States and Canadian Academy of Pathology (USCAP)

SUNNYVALE, Calif., March 5 /PRNewswire/ -- Impac Software, part of the Elekta Group and leading provider of software solutions for anatomic pathology (AP) laboratories today announced the introduction of PowerPath version 9.3, including new features and interfaces - all to be demonstrated at USCAP conference in Boston, March 9-11, 2009. PowerPath v9.3 includes updates to the Advanced Materials Processing (AMP) module and the Document Management module, as well as new interfaces for digital pathology and diagnostic reference systems.

Advanced Materials Processing (AMP) version 3

The AMP materials tracking solution drives the workflow of a histology lab by tracking materials through the lab - from the receipt and processing of tissue specimens, through the creation and tracking of blocks and slides, to managing specimen discard.

Document Management

Batch processing has been added to this popular feature to further streamline administrative tasks in the lab. Users can now process many documents at once using our bar coding technology. Simply label the documents for the case--then set aside the paperwork, and scan the entire set as a batch when convenient. PowerPath reads the bar code and auto assigns documents to respective PowerPath cases.

Digital Pathology Interfaces

This interface connects PowerPath to the digital pathology system to optimize case workflow.

The interface is bi-directional and keyed from the bar coded slides generated by PowerPath's AMP module. Upon completion of the slide imaging event, slide thumbnails and region of interest images are sent to PowerPath to store with other case data.

Diagnosis Reference Integration

Users may access the experts from the PowerPath case by automatically linking to their PathIQ(R) ImmunoQuery(R) Custom Sync(TM) subscription. With this interface, users may view recommendations for special stains and published study reference materials.

"Impac Software is committed to integrating new technology with PowerPath," says George Rugg, SVP and General Manager of Impac's LIS business unit, "and as an LIS provider we recognize that these systems produce data which must be integrated with other case information. Lab technology is advancing so rapidly that the only way to accomplish this is with frequent releases and easy access to those releases through a streamlined upgrade program. Impac Software does both."

Demonstrations of the new features and interfaces available with PowerPath version 9.3 will be available March 9-11 at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in Boston, Massachusetts. PowerPath demonstrations also will be available at the Royal College of Pathologists of Australasia (RCPA) Pathology Update 2009 conference, March 13-15, in Sydney Australia and the Lab InfoTech Summit March 16-18 in Las Vegas, Nevada. For additional information, visit Impac booth 726 at USCAP, Impac booth 26 at RCPA, and Impac booth 19 at Lab InfoTech Summit, or visit us online at www.impac.com/pathology.

About Impac Software

Impac Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Impac's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory and cancer registry.

Today, Elekta solutions are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group. Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information, visit www.impac.com or www.elekta.com.


'/>"/>
SOURCE Impac Software
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Insurance Impacts Laryngeal Cancer Detection
2. HIVs impact in Zimbabwe explored in new research
3. NYU study points to lasting impact of mild hearing loss on neurological processes
4. Limiting Residents Hours Has Little Impact on Patient Mortality
5. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
6. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care
7. IMPACT initiative looks to improve patient participation in clinical trials
8. ER episode impacts viewers health knowledge and behavior
9. Decision-making by residents on-call has miniscule negative impact on patient care
10. ER episode impacts viewers health knowledge and behavior
11. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Journal of Oral Implantology ... have severe consequences to overall dental health, including complications with speech, eating, and overcompensation ... dental implants to replace lost teeth. As the number of tooth replacements increase, it ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... Hackensack, N.J. has been honored by Enterprising Women magazine as one of its ... world’s top women business owners. Winners have demonstrated that they have fast-growth businesses, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the ... Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market ... Low drug registration cost in Latin American countries and ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: